Noticias de WGS_US

Mercado

Noticias del mercado

Últimas noticias sobre WGS_US — 114 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: WGS_US ✕ 114 resultados
07/10/2026 WGS_US — Stock Titan
Eight babies with a heart rhythm condition began treatment after DNA screening

72.3% of families approached enrolled; 76% of participating newborns represented non-European genetic ancestry. BRIDGES-NBS will begin enrolling this month.

05/10/2026 WGS_US — Stock Traders Daily
Discipline and Rules-Based Execution in WGS Response

Price-action only: Genedx Holdings Corp. (WGS) movements set the tone for institutional models. Discipline and Rules-Based Execution in WGS Response

02/10/2026 WGS_US — Yahoo Finance
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

GAITHERSBURG, Md., October 02, 2026--GeneDx introduces Easy Order at AAP 2026 to simplify genomic testing in everyday pediatric care

01/10/2026 WGS_US — Yahoo Finance
GeneDx Holdings Corp. (WGS) Options Chain

View the basic WGS option chain and compare options of GeneDx Holdings Corp. on Yahoo Finance.

29/09/2026 WGS_US — ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 29, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx ...

27/09/2026 WGS_US — scanx.trade
GeneDx to report Q2 2026 financial results on August 3

GeneDx anunciará sus resultados financieros del segundo trimestre de 2026 el 3 de agosto de 2026, seguido de una conferencia telefónica a las 4:30 p.m. hora del este. Los inversores pueden acceder al evento vía webcast en la empresa

22/09/2026 WGS_US — ACCESS Newswire
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx ...

Página 2 de 6